Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir Saheb

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Future Cardiology|June 23, 2025
Long-term safety and effectiveness of evinacumab in people with homozygous familial hypercholesterolemia: a plain language summaryDaniel Gaudet, Susanne Greber-Platzer, Laurens F Reeskamp, et al.
European Heart Journal|June 10, 2024
Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacyDaniel Gaudet, Susanne Greber-Platzer, Laurens F Reeskamp, et al.
Atherosclerosis|March 22, 2020
Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registryIlse K Luirink, Barbara A Hutten, Susanne Greber-Platzer, et al.
Plos One|May 4, 2010
Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experiencePaul Coppo, Michael Schwarzinger, Marc Buffet, et al.
Blood|September 12, 2018
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpuraMatthieu Jestin, Ygal Benhamou, An-Sofie Schelpe, et al.
Frontiers in Immunology|February 3, 2025
Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19Aurelie Guironnet-Paquet, Hind Hamzeh-Cognasse, Frederic Berard, et al.
Blood|September 19, 2019
Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survivalRenaud Prevel, Claire Roubaud-Baudron, Samuel Gourlain, et al.
Orphanet Journal of Rare Diseases|September 9, 2021
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective surveyLaura D'Erasmo, Antonio Gallo, Angelo Baldassare Cefalù, et al.
Cancer Discovery|February 23, 2023
Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor MyocarditisJoe-Elie Salem, Marie Bretagne, Baptiste Abbar, et al.
American Journal of Ophthalmology|February 23, 2023
Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis AttacksJohn J Chen, Eoin P Flanagan, Sean J Pittock, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Future Cardiology|June 23, 2025
Long-term safety and effectiveness of evinacumab in people with homozygous familial hypercholesterolemia: a plain language summaryDaniel Gaudet, Susanne Greber-Platzer, Laurens F Reeskamp, et al.
European Heart Journal|June 10, 2024
Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacyDaniel Gaudet, Susanne Greber-Platzer, Laurens F Reeskamp, et al.
Atherosclerosis|March 22, 2020
Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registryIlse K Luirink, Barbara A Hutten, Susanne Greber-Platzer, et al.
Plos One|May 4, 2010
Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experiencePaul Coppo, Michael Schwarzinger, Marc Buffet, et al.
Blood|September 12, 2018
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpuraMatthieu Jestin, Ygal Benhamou, An-Sofie Schelpe, et al.
Frontiers in Immunology|February 3, 2025
Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19Aurelie Guironnet-Paquet, Hind Hamzeh-Cognasse, Frederic Berard, et al.
Blood|September 19, 2019
Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survivalRenaud Prevel, Claire Roubaud-Baudron, Samuel Gourlain, et al.
Orphanet Journal of Rare Diseases|September 9, 2021
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective surveyLaura D'Erasmo, Antonio Gallo, Angelo Baldassare Cefalù, et al.
Cancer Discovery|February 23, 2023
Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor MyocarditisJoe-Elie Salem, Marie Bretagne, Baptiste Abbar, et al.
American Journal of Ophthalmology|February 23, 2023
Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis AttacksJohn J Chen, Eoin P Flanagan, Sean J Pittock, et al.
Pageof 4